Core Viewpoint - The legal opinion confirms that the procedures, qualifications, and voting results of the Shanghai Kelaimechatronic Automation Engineering Co., Ltd. 2025 Second Extraordinary General Meeting of Shareholders comply with relevant laws and regulations [11]. Group 1: Meeting Procedures and Qualifications - The meeting was convened by the company's board of directors and announced on May 24, 2025, with a notice published 15 days prior to the meeting [2][3]. - The meeting took place on June 10, 2025, at 10:00 AM, combining on-site and online voting methods [3]. - A total of 15 shareholders and their proxies attended the on-site meeting, while 279 shareholders participated via online voting, representing 2,197,001 shares, or 0.8353% of the total voting shares [4][5]. Group 2: Voting Results - The meeting approved several resolutions, with the first non-cumulative voting resolution receiving 110,785,573 votes in favor, accounting for 99.7560% of the total votes cast [5]. - Subsequent resolutions also received significant support, with votes in favor ranging from 98.6007% to 99.7560%, indicating strong shareholder approval [6][7][9]. - The resolutions passed were consistent with the items listed in the meeting notice, with no new proposals introduced [5][11].

法律意见书 二〇二五年六月 北京市中伦（广州）律师事务所 北京市中伦（广州）律师事务所 关于广州白云山医药集团股份有限公司 关于广州白云山医药集团股份有限公司 法律意见书 致：广州白云山医药集团股份有限公司 北京市中伦（广州）律师事务所（以下简称"本所"）接受广州白云山医药 集团股份有限公司（以下简称"公司"）委托，指派刘子丰律师和曾思律师（以 下简称"本所律师"）对公司 2024 年年度股东大会（以下简称"本次股东大会"） 的合法性进行见证并出具法律意见。 本所及本所律师依据《中华人民共和国证券法》（以下简称"《证券法》"）、 《律师事务所从事证券法律业务管理办法》和《律师事务所证券法律业务执业规 则（试行）》等规定及本法律意见书出具日以前已经发生或者存在的事实，严格 履行了法定职责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证，保 证本法律意见所认定的事实真实、准确、完整，所发表的结论性意见合法、准确， 不存在虚假记载、误导性陈述或者重大遗漏，并承担相应法律责任。 本法律意见书根据《中华人民共和国公司法》 （以下简称"《公司法》"）、 《证 券法》等现行有效的法律、法规、规范性文件以及《广州白云山医 ...